IDEXX LABORATORIES INC /DE Annual Report, Year Ended Dec 31, 2015

IDEXX Laboratories, Inc. (IDXX) reported strong revenue growth for the fiscal year ending December 31, 2015, driven primarily by its Companion Animal Group (CAG) segment. The company's strategic shift to an all-direct sales model in the U.S. for certain products, implemented at the beginning of 2015, appears to be positively impacting revenue and customer relationships, despite initial transition costs. International sales continue to be a significant contributor to overall revenue, although the strengthening U.S. dollar presented a headwind. The company maintained a focus on innovation, with new product introductions and continued investment in research and development. Financial performance demonstrated growth in gross profit and operating income, excluding certain one-time transition costs. The company's commitment to returning value to shareholders is evident through its ongoing share repurchase program, with no intention to pay dividends at this time. IDEXX's diversified business across veterinary diagnostics, water testing, and livestock/poultry/dairy markets, coupled with its strong market position, provides a resilient business model. Investors should note the company's ongoing efforts to expand its product offerings and its management of supply chain and competitive risks.